Abstract:Fain A s diabetes educators, we spend a great deal of time working with individuals in an outpatient setting, helping them to manage their blood glucose levels on a daily basis. While educating individuals about how food, activity levels, illness, or medication affects blood glucose levels, we continually stress the importance of keeping blood glucose levels in the recommended target range to prevent or delay long-term health problems associated with diabetes. What happens when individuals with diabetes are hospitalized for heart disease, infections, surgery, or cases of emergency? Unfortunately, glucose control has not been a focal point of discussion among clinicians because of a lack of published guidelines/protocols and/or a lack of evidence demonstrating high glucose levels associated with poor outcomes. For many years, emphasis on inpatient diabetes care has focused on treating individuals admitted with diabetic ketoacidosis or educating patients who were newly diagnosed with diabetes. Diabetes self-management education concerning issues related to improving inpatient glucose control has not received adequate attention. Results from several epidemiological studies strongly suggest that patients with diabetes have an increased morbidity and mortality associated with myocardial infarction, coronary artery bypass, and stroke. In all instances, high blood glucose levels were associated with a poor outcome. How then do we focus on improving inpatient glucose control? In January 2006, representatives from the American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), and American Diabetes Association (ADA) held a Consensus Conference titled “Improving Inpatient Diabetes Care: A Call to Action.” In addition to the AACE, ACE, and ADA, other major organizations helped cosponsor the conference including the American Association of Diabetes Educators, American Heart Association, and Society of Critical Care Medicine, to name a few. The conference addressed strategies for the implementation of glucose control in hospitalized patients as well as reviewed protocols that have been successful for hospitals across the nation. Proceedings from the conference outline the evidence in support of inpatient glucose control and identify areas needing further research. In this issue of The Diabetes Educator, Osburne and colleagues provide readers with the results of a quality improvement project assessing the feasibility of a nursedriven effort to improve hyperglycemia in an intensive care unit. A sample guideline is provided that includes best practices created by a multidisciplinary team to improve care of individuals with diabetes. Osburne’s article is the first of several other articles to be published on the topic of inpatient glucose control in the next couple of issues of The Diabetes Educator. While the topic of inpatient diabetes care and glucose management has not received a lot of attention, an increased awareness has begun to occur with the development of new protocols/guidelines that hospitals can use in caring for patients with diabetes. EDITORIAL I I

Antiosteoporotic Flavonoids From Podocarpium Podocarpum

Antiosteoporotic activity of phenolic compounds from Curculigo orchioides

Two new flavonoid glucosides from Penthorum chinense Pursh

The Phenolics from the Roots of Livistona Chinensis Show Antioxidative and Obsteoblast Differentiation Promoting Activity

Three New Isoflavonoid Glycosides From The Mangrove-Derived Actinomycete Micromonospora Aurantiaca 110b

Discovery of a Potent Antiosteoporotic Drug Molecular Scaffold Derived from Angelica sinensis and Its Bioinspired Total Synthesis

Alleviation of Podophyllotoxin Toxicity Using Coexisting Flavonoids from Dysosma Versipellis.

Bioactive steroids from the brown alga Sargassum carpophyllum

Lichen planus and abnormal transaminases: a clue to hepatitis C infection.

A new coumarin and a new flavonoid from Ochrocarpus longifolius

Flavonoids Isolated from Sinopodophylli Fructus and Their Bioactivities Against Human Breast Cancer Cells

Flavonoid glycosides isolated from Epimedium brevicornum and their estrogen biosynthesis-promoting effects

Two novel butyrolactone lignan dimers from leaves of Castanopsis chinensis and their anti-inflammatory activities

Sophoraflavanone G Inhibits RANKL-Induced Osteoclastogenesis via MAPK/NF-κB Signaling Pathway

Improving Inpatient Glucose Control

Investigation of the Lignan Content in Extracts from Linum, Callitris and Juniperus Species in Relation to Their In Vitro Antiproliferative Activities

Flavonoid constituents of Astragalus membranaceus var. mongholicus

WDM-Enabled Optical RAM at 5 Gb/s Using a Monolithic InP Flip-Flop Chip

Antiosteoporotic Tetrahydroxanthone Dimers from Aspergillus brunneoviolaceus FB ‐2 Residing in Human Gut

Total Flavonoids of Drynariae Rhizoma Improve Glucocorticoid-Induced Osteoporosis of Rats: UHPLC-MS-Based Qualitative Analysis, Network Pharmacology Strategy and Pharmacodynamic Validation

Development of a DNA microarray-based multiplex assay of avian influenza virus subtypes H5, H7, H9, N1, and N2.